Bladder Cancer
Computational Analysis of N6-Methyladenosine Regulators and Long Non-Coding RNAs in Bladder Cancer - Expert Commentary
February 13, 2023
N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer.
February 13, 2023
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort Evaluation.
February 13, 2023
Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer.
February 13, 2023
BCG shortage for intravesical instillation is associated with early tumoral recurrence in patients with high-risk non-muscle invasive bladder tumours.
February 10, 2023
Prognostic impact of variant histologies in urothelial bladder cancer treated by radical cystectomy.
February 9, 2023
Preoperative Cell-Free DNA (cfDNA) in Muscle-Invasive Bladder Cancer Treatment Outcome.
February 9, 2023
Robot-assisted vs. open radical cystectomy: systematic review and meta-analysis of randomized controlled trials.
February 7, 2023
Efficacy and Feasibility of Pre-surgical Exercise in Bladder Cancer Patients Scheduled for Open Radical Cystectomy.
February 6, 2023
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
February 6, 2023
Health-Related Quality of Life after Robotic-Assisted vs Open Radical Cystectomy: Analysis of a Randomized Trial.
February 3, 2023
Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer.
February 3, 2023
Impact of Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer - Expert Commentary
February 2, 2023
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic
February 2, 2023
News in the classification of WHO 2022 bladder tumors.
February 2, 2023